$LPTX

Leap Therapeutics Inc

  • NASDAQ
  • Health Technology
  • Biotechnology
  • Manufacturing
  • Pharmaceutical Preparation Manufacturing

PRICE

$2.39 -

Last Close

VOLUME

1,440,194

DAY RANGE

2.35 - 2.52

52 WEEK

1.33 - 4.17

Join Discuss about LPTX with like-minded investors

SO
@soheil.n #StockTraders.NET
recently

IU Watchlist: Main Watches: $CEI solid action today - pressure into the after hours session and IMO lots of exits into close (covers) for fear of another AHs type of move. Likelihood of a gap down is real and the only thing that would be a buzz kill off open tomorrow is a flush -10% to trigger the damn SSR again and then consolidate it through the day. There is too much volume to just "die" and that's that - it's not that kind of play. This will take time to fail - the reason it's here is b/c everyone wants it to fail. Trade it - or forget it. If you stay and pray you're going to get beat. Each day this week they've respected the levels to a tee. If it doesn't consolidate sideways through the day after triggering SSR and stays heavy it can fade off $2.60-2.80s slowly. $PALT big one today - I started in some, stopped before it became an issue we got that big gap and I scaled scaled scaled for a nice unwind. That was the main focus for me - clean fader off the PR which by the way was something we used to see in OTC companies "We got a new PR firm" this should continued to unwind likely gaps down but today was just a bunch of buy ins. $DATS got pumped AHs as if the Form 4s were insider buys meanwhile they are grants etc. Killer trader today love how it's trading in tandem with CEI makes the trade much easier. Again as reminded today if you're trading it and it flushes - don't try to be a hero and fade it the entire day. Take advantage of the range and move on. Failed Follow Through: $BBBY morning shove and looking for pressure to join 945-10AM+ $PLTR nice one today 945-10AM + trend join - I have it under failed follow through b/c I do think we could see a gap and fade but if we start to see a trend hold vs. VWAP I'd consider a long. Continuation: $BBIG nice idea on scan last night - load zone for me was $5.80-6s I did not expect it to rip as far as it did today so I sold some around the core. Same thought process as scan last night. $LPTX so far so good - been adding dips I won't chase this - easily can just come right back in I'd rather see it get away from $4s now and build a new base before scaling up. $JSPR nice rip back today - that bag was getting heavy. I didn't sell it b/c I had sold some at $15s + from the $12s accumulation then I woke up with a GREE home run yesterday so I let it go, then I woke up with FAMI home run this AM so I let it go meanwhile JPSR just down down down taking those gains away - got a bit of a footing today went back to flat on it before fading off some. We'll see. My plan wasn't to marry it. Still a bag but less of a bag down a buck. $RCAT liquidity trap potential if we get a PR or $3.80s start to base we could have a wild move $3.50s really the key level for risk. I bought today was looking to really scale up if it set up but unfortunately didn't. Sold my day trades but kept the early snag as a big picture and to remember -- will scale if trend holds. $FAMI big way to wake up today sold 3/4 over .50 then it flushed sold rest then it came back over -- held well I bought small at close in case .03-.05 gap up then thinking it's done. Nothing to over stay. Nice one today. $DOGZ dips keep getting soaked. Still cautiously interested.

50 Replies 7 👍 8 🔥

SO
@soheil.n #StockTraders.NET
recently

IU Watchlist: Main Watches: $CEI had one failed follow through set up but never breached VWAP - the slow steady grind with re checks of prior support levels numerous times can last a long time. The volume is picking back up so this has become less of a social medial hype and at this point shorts letting shorts out letting shorts out letting shorts out creating lots of volume kicking the can down the road while the float is held tightly. We are nearing the speed up move. Ideally we get some sorta $3 gap $3.50-4 parabolic like SNDL way back when. Pretty impressive so far. $MMAT has a vote tomorrow not sure what time but I'll check in the morning -- but may be a trade surrounding that. Failed Follow Through: $MRIN higher better and fails $RCAT faded AHs but ideally pushes back up on $3.50+ then failed follow through $DATS keeps getting saved but it offered some nice trades today. If you are looking for the unwind trade don't bother. Trade trend or leave it alone. At some point CEI DATS etc will have a reset day but that's not to anticipate -- that's for after trends break. $ATUS morning shove 945-10AM + looking to fade maybe sub 18s Continuation: Been spreading IRA out a lot lately - had some fire sales and then re joined bunch of names but likely have another fire sale soon. Lots of swings working but also don't want to get sloppy just throwing $$ at names. The BBIG trade this AM worked out well from continuation idea on Friday but throwing it too fast at subpar trades easy to give back $ quick. Lots in the LCID basket XL RMO VLDR FSR LAZR etc all worked well - that event is tomorrow so could be volatility in the space. TSLA insane SOLO etc. $MDIA letting some work until it doesn't - nice grind today didn't trust much size since no vol. $JSPR if I didn't sell some into the break out on Friday I'd be down about .50-.70/share or so on this trade I was up about $3/share going into weekend but it came back in today - still sorta part of the plan tho, not the volume today liquidity trap etc. I did sell some into power on Friday and my goal is only weakness only flushes if this starts to hold oddly well again or get a PR it's set up perfect for what we've seen lately. So, we'll see. One thing is for sure - if you chased it for whatever reason make sure your risk is in check and don't do anything silly as my plan was accumulation on weakness when no one wants it -- not into power or strength. $NAKD big one -- I prob sold too much worked pretty perfect sold a bit more over .90s and have a bit left. Prob won't last too much longer unless we get a reset day and it stays firm after that. Nice job all. $LICY just letting it work until fails Barron's helping this along. $HUSA so far so good $LXRX like this chart - no position. $MOXC started in some long today had some calls worth eyeing. $SNMP finally over that $1.20 worthy eye at this point - added some today. $ACHV trimmed some today from last weeks snag. $EBET joined trend today maybe gets a circuit style move in coming days reminds me of EEIQ $LPTX started in from the Sunday night game plan $3.4x's and some adds.

132 Replies 13 👍 13 🔥

profile
@maletone #StockTraders.NET
recently

missed such an easy short on $LPTX damn

60 Replies 7 👍 6 🔥

profile
@thegiz18 #ivtrades
recently

Penny $LPTX has been on a tear with big volume the past week

67 Replies 7 👍 9 🔥

profile
@Baljit123 #StockTraders.NET
recently

Tom Watchlist. MIC. LPTX LHF - 2.5 - 3 area of interest for me, stop over 3 as i dont think it should get there.

123 Replies 14 👍 6 🔥

profile
@maletone #StockTraders.NET
recently

nice short on $LPTX

95 Replies 10 👍 15 🔥

profile
@nepestheone #StockTraders.NET
recently

TLM Watchlist CEI- retest of 1.65-1.80 for possible 1.30s-1.20s [9:17 AM] LPTX- pops to 2.75-2.95 for short then over under 3 [9:17 AM] INDP watching 15 zone as gauge for reshort

85 Replies 10 👍 11 🔥

profile
@Baljit123 #StockTraders.NET
recently

MIC watchlist. Alex. 16:09:21 LPTX - Looking for a morning pop toward 2.80 / 3.00 to short. If we tank out the open will look for a VWAP rejection IRNT - This should be AVOIDED both long and short. Very trappy action both ways and very expensive to borrow. I'm sure there will be easier setups INDP - I think this can run to 14 / 15 at the open before coming abc down to reality. I will be waiting for a DEATH CANDLE then will short a bounce. More commentary at open TMC - Potential hot chick. ETB and SSR. This should be 30% max size and nail and bail ONLY. Maybe a 15 rejection to short with a 16 STOP OPAD - Waiting for the chart to form more here. Ideally a big tank at the open, then a rebound to short into. All of these are gonna be important to see where the money flows at the open -- The JumpStart Accelerator Course Is Now AVAILABLE!!!: https://myinvestingclub.com/jumpstart/

74 Replies 12 👍 10 🔥

profile
@maletone #StockTraders.NET
recently

watch list for tomorrow: $LIFE, $LPTX, $DTss, $GSAT going into apple event

74 Replies 7 👍 8 🔥

profile
@Baljit123 #StockTraders.NET
recently

mic watchlist ISEE - This trapped shorts last week and ETB again today. I think this will trap shorts again, I am not interested in shorting this BBIG - 10.70 / 11.00 / 11.20 lines to scale in short SPRT - This is an AVOID for me because I just dont understand it AFRM - I saw people trading this last week. IGNORE THIS LONG AND SHORT IT IS NON NICHE! LPTX - Ideally morning pop toward 2.20 / 2.40 in the morning to short. DRAW YOUR LINES! BLU - Potential HOT CHICK due to ETB. Ignoring this short side for now EFTR - Waiting for a DEATH CANDLE after the pumpers are done then will attack -- The JumpStart Accelerator Course Is Now AVAILABLE!!!: https://myinvestingclub.com/jumpstart/

121 Replies 15 👍 6 🔥

profile
@DarkPoolAlgo #Dark Pool Charts
recently

Monday, September 13, 2021 Futures Up/Down % Last Dow 233.00 0.68% 34,724 S&P 500 27.25 0.61% 4,476 Nasdaq 80.50 0.52% 15,514 Stock futures are looking sharply higher, with the S&P trying to snap its longest losing streak since February (5-days currently) ahead of key economic data this week (CPI and retail sales). Stocks are recovering despite a handful of negative headlines this weekend including a WSJ article that House Dems are considering a 26.5% corporate tax rate from 21.5% with a 3% surtax on individual incomes over $3m, & increasing higher rate capital gains tax to 28.8% from 23.8%. Also this weekend, Sen. Joe Manchin said this weekend he would not vote for the $3.5 trillion budget bill, adding that there’s “no way” to meet the September 27 deadline. In Asian markets, The Nikkei Index gained 65 points to 30,447, the Shanghai Index rose 12 points to 3,715 and the Hang Seng Index dropped -392 points (1.5%) to settle at 25,813. In Europe, the German DAX is surging over 175 points (1.1%) to 15,785, while the FTSE 100 is up over 50 points to 7,075. Stocks slipped all last week as the S&P fell 1.7%, the Dow lost 2.15%, the Nasdaq shed 1.61% as the S&P 500 extended its losing streak to 5-days, the longest since the middle of February. The S&P 500 has rallied over 38% without a 5%+ pullback over the last 309 calendar days. With the European Central Bank offering only a partial tapering of its bond purchases last week, while boosting growth forecasts, investors are now looking at an autumn glide path for stocks based on a similar move by the Federal Reserve later this month. Markets will closely watch the CPI inflation reading after another rise in producer prices (PPI) late last week. Market Closing Prices Yesterday The S&P 500 Index dropped -34.70 points, or 0.77%, to 4,458.58 The Dow Jones Industrial Average fell -271.66 points, or 0.78%, to 34,607.72 The Nasdaq Composite dropped -132.76 points, or 0.87%, to 15,115.49 The Russell 2000 Index declined -21.58 points, or 0.96% to 2,227.55 Events Calendar for Today 2:00 PM ET Federal Budget for August Earnings Calendar: Earnings Before the Open: NSSC, SEAC Earnings After the Close: AVO, CSBR, EPM, ICMB, MTRX, ORCL, RFIL, VOLT Other Key Events: Barclay’s Financial Services Conference (virtual) 2021, 9/13-9/15 BMO Capital 2021 Real Estate Conference (virtual), 9/13-9/14 Citigroup 2021 Global Technology Conference (virtual), 9/13-9/15 Cowen 2nd Annual Health, Wellness & Beauty Summit (virtual), 9/13-9/14 Credit Suisse 34th Annual Basic Materials Conference (virtual), 9/13-9/14 Deutsche Bank 11th Annual Aircraft, Finance & Leasing Conference, 9/13-9/14, in NY JPMorgan Gaming, Lodging, Restaurant & Leisure Management Forum, 9/13-9/14 Piper Global Technology Conference (virtual), 9/13-9/14 Piper 2021 D.C. Bank Field Trip, 9/13-9/15 Wells Fargo 10th Annual Lease REIT Forum (virtual), 9/13 Macro Up/Down Last Nymex 0.96 70.68 Brent 0.86 73.78 Gold +0.90 1,788.50 EUR/USD -0.0033 1.1781 JPY/USD 0.18 110.12 10-Year Note -0.005 1.336% World News House Democrats expect to propose raising the corporate tax rate to 26.5% from 21% and imposing a 3-percentage-point surtax on individual income above $5 million, according to two House Democratic aides familiar with the plans, the WSJ reported. The tax increases would be part of the House Ways and Means Committee’s plans to pay for the party’s priorities in a fast-moving budget bill. Those items include an expanded child tax credit, a national paid-leave program and renewable-energy tax breaks. Joe Manchin said this weekend he would not vote for the $3.5 trillion budget bill, adding that there’s “no way” to meet the September 27 deadline set by House Speaker Nancy Pelosi. Manchin’s comments come as lawmakers work to approve the measure which would invest in climate policy and expand social programs North Korea carried out successful tests of a new long-range cruise missile over the weekend, state media said on Monday Sector News Breakdown Consumer Homebuilders R. Horton ($DHI) and Meritage $(MTH) still look like relative bargains according to Barron’s saying when it comes to builders, book value may no longer be the only metric to look at. DHI, MDC and MTH look historically cheap based on current price/earnings, noting Wall Street analysts see double-digit gains ahead Boston Beer ($SAM) shares tumbled this week after warning of decelerating had seltzer category, with Barron’s saying with the stock now worth less than half what it was at its peak, it might be time to take a look at shares. The stock now looks to have support near $500, around its June 2020 lows. If that level holds, buying the stock in the low $500s could turn out to be a smart bet Toyota Motor Corp ($TM) and Honda Motor Co ($HMC) on Saturday sharply criticized a proposal by Democrats in the U.S. House of Representatives to give union-made electric vehicles in the United States an additional $4,500 tax incentive. Leslie’s ($LESL) files to sell 13M shares of common stock for holders MGM Resorts ($MGM) upgraded to Outperform from Market Perform at Bernstein Nike ($NKE) downgraded to Neutral from Buy at BTIG Stanley Black & Decker ($SWK) announced that it has entered into a definitive agreement to acquire Excel Industries for $375 million in cash. Energy, Industrials and Materials Virgin Galactic ($SPCE) said this weekend that the flight window for Unity 23 will be pushed back to mid-October at the earliest after a third-party supplier flagged a potential manufacturing defect in a component of the flight control actuation system. It is not yet known if the defect is present in any of Virgin’s vehicles or any repair work will be needed. Kansas City Southern (KSU) said on Sunday it planned to accept Canadian Pacific Railway’s ($CP) $27.2 billion cash-and-stock acquisition offer as superior to its $29.6 billion deal to sell itself to Canadian National Railway ($CNI), according to Reuters. Canadian National now has until the end of Friday to submit a better offer or lose its deal with Kansas City Southern. Rocket Lab USA ($RKLB) mentioned cautiously in Barron’s saying after a strong run for shares, it’s time to think about taking some profits. Recent positive news has sent shares skyrocketing, leaving even the most bullish investors wondering that to do next Atlas Air Worldwide ($AAWW) subsidiary, Atlas Air completes five-year joint collective bargaining agreement for its Atlas Air and Southern Air pilots. Trane Technologies ($TT) signed an agreement to acquire Farrar Scientific, a leader in ultra-low temperature control for biopharmaceutical and other life science applications for $250M US Well Services ($USWS) said it received written notice from the Nasdaq on Sept 7 indicating it had failed to comply with the minimum closing bid price requirement rule and will therefore be de-listed Louisiana declared a state of emergency ahead of Tropical Storm Nicholas Financials Beijing wants to break up Alipay, the hugely popular payments app owned by Jack Ma’s Ant Group, and create a separate app for the company’s highly profitable loans business, the Financial Times reported on Sunday. The plan will also see Ant turn over the user data that underpins its lending decisions to a new credit scoring joint-venture, which will be partly state-owned, the newspaper reported TransUnion ($TRU) said it has agreed to buy information-services company Neustar Inc. for $3.1 billion in cash, a move that sets the consumer-credit reporting giant to diversify beyond its core business and put data to new uses. The Chicago-based company Monday said it is buying Neustar from a private investment group led by Golden Gate Capital https://on.mktw.net/3tBRVou SVB Financial Group ($SIVB) mentioned positively in Barron’s saying the bank stands out in the stodgy world of banking because of its unusual role as a leading lender to innovative tech start-ups. While some banks have struggled to grow their loan book over the past year, SVB had 8% QoQ growth in loan balances, reflecting strong activity in the tech and healthcare sectors KeyCorp (KEY) sold its $3.2B indirect retail auto loan portfolio to a vehicle managed by a subsidiary of Waterfall Asset Management, and will use capital generated by the sale to buy back some of its stock. Healthcare Dynavax ($DVAX) shares slide -16%; as the British government ends a COVID-19 vaccine supply deal with French vaccine maker Valneva SE, alleging a breach of obligations that Valneva denies. Valneva is developing its COVID-19 vaccine, VLA2001, combined with DVAX’s adjuvant or vaccine booster, CpG 1018 AbbVie ($ABBV) and REGENXBIO ($RGNX) form a strategic partnership combining eye care and gene therapy expertise- Companies will develop and commercialize RGX-314, an investigational gene therapy for wet age-related macular degeneration, diabetic retinopathy and other chronic retinal diseases- REGENXBIO to receive $370 million upfront payment Leap Therapeutics ($LPTX) said it will be presenting initial data from the first-line cohort of the DisTinGuish study, a Phase 2a clinical trial evaluating Leap’s anti-Dickkopf-1, or DKK1, antibody, DKN-01, in combination with tislelizumab, BeiGene’s anti-PD-1 antibody, and chemotherapy, in patients with gastric or gastroesophageal junction cancer, at the European Society for Medical Oncology, or ESMO, Congress, being held virtually on September 16-21 MiMedx Group (MDXG) shares fall -19% as reports Top-line Data from Two Late-Stage Musculoskeletal Trials. Top-line results from an interim analysis of the Phase 2B trial for KOA did not meet primary endpoints. Top-line results from Phase 3 Plantar Fasciitis trial did not meet its primary endpoints. Israel is considering a fourth round of coronavirus vaccines, Bloomberg News reported, citing an interview a health ministry official. mostly uses the vaccine made by Pfizer ($PFE) and BioNTech ($BNTX), but also uses Moderna ($MRNA) Hepion Pharmaceuticals ($HEPH) schedules conference call to review data from phase 2a ‘AMBITION’ clinical trial of CRV431 in NASH; it expects to release additional data from its Phase 2a ‘AMBITION’ NASH clinical trial before the market opens on Monday, September 13, 2021. Technology, Media & Telecom Cisco ($CSCO mentioned in Barron’s noting the company is meeting with analysts on Wednesday for the first time in four year and the session could make or break the shares. The networking giant’s sales suffered last year as companies cut information technology spending early in the pandemic. But the trend has reversed in Cisco’s favor ViacomCBS Inc ($VIAC) is revamping the operations of its Paramount Pictures movie and television production unit under a broader management shake-up, the Wall Street Journal reported on Sunday, citing people familiar with the matter. The realignment will see Paramount Television expected to focus primarily on making content for its sister cable and streaming networks Canon ($CAJ) announced that it has reached an agreement with Redlen Technologies to conclude a share transfer agreement, making Redlen a wholly owned subsidiary of Canon

89 Replies 8 👍 7 🔥

profile
@thegiz18 #ivtrades
recently

Some smaller dollar biotech stocks to watch today for movement, $CLVS, $LPTX, $AVEO, $CRDF

54 Replies 15 👍 8 🔥

Key Metrics

Market Cap

211.08 M

Beta

0.56

Avg. Volume

1.84 M

Shares Outstanding

88.32 M

Yield

0%

Public Float

0

Next Earnings Date

2022-03-11

Next Dividend Date

Company Information

Leap Therapeutics is focused on developing targeted and immuno-oncology therapeutics. Leap's most advanced clinical candidate, DKN-01, is a humanized monoclonal antibody targeting the Dickkopf-1 (DKK1) protein, a Wnt pathway modulator. DKN-01 is in clinical trials in patients with esophagogastric, hepatobiliary, gynecologic, and prostate cancers. Leap has entered into a strategic partnership with BeiGene, Ltd. for the rights to develop DKN-01 in Asia (excluding Japan), Australia, and New Zealand.

Website:

HQ: 47 Thorndike St Ste B1-1 Cambridge, 02141-1799 Massachusetts

Related News